» Articles » PMID: 23341370

Prevalence and Risk Factors of Hepatitis C and B Virus Infections in Hemodialysis Patients and Their Spouses: a Multicenter Study in Beijing, China

Overview
Journal J Med Virol
Specialty Microbiology
Date 2013 Jan 24
PMID 23341370
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Hemodialysis patients are at risk for hepatitis C and B virus infections. This study investigated the prevalences and risk factors of HCV and HBV infection and the distribution of HCV genotypes among hemodialysis patients and their spouses. From August to November 2011, a cross-sectional study was conducted on 20 hemodialysis units in Beijing to investigate prevalences and risk factors for markers of HCV and HBV among 2,120 patients and 409 spouses. In hemodialysis patients, prevalences of anti-HCV, HCV RNA, and hepatitis B surface antigen (HBsAg) were 6.1%, 4.6%, and 7.0%, respectively. The prevalence of HCV antibodies among spouses was 0.5%, of HCV RNA was 0.2%, and of HBsAg was 4.2%. Risk factors for HCV infection were dialysis duration, blood transfusion, and attending more than one dialysis unit. HBV infection was independently associated with age, family member with hepatitis infection, gender, and surgery. The predominant HCV genotypes were 1b (89.0%) and 2a (7.7%), and genotypes 3a, 3b, and 6a were each 1.1%. A significant decrease in HCV and HBV prevalences in Chinese dialysis units showed that infection control measures were effective. However, because nosocomial transmissions persist, strict adherence to infection control measures should be emphasized to reduce the risk of transmission.

Citing Articles

The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients.

Abd Elaziz M, Mustafa Gouda Elewa A, Zaki Mohamed Zaki Abdel Hamid D, Essam Soliman Ahmed Hassan N, Csongradi E, Mohammed E Ren Fail. 2024; 46(1):2346284.

PMID: 38757700 PMC: 11104698.


Prevalence of HCV Infection Among Hemodialysis Patients in Lanzhou of Northwestern China.

Bao K, Chen J, Liu R, Xiang Y, Gao W Infect Drug Resist. 2022; 15:5609-5617.

PMID: 36172622 PMC: 9512538. DOI: 10.2147/IDR.S378600.


Meta-analysis: risk of hepatitis C virus infection associated with hospital-based invasive procedures.

Henriot P, Castry M, Luong Nguyen L, Shimakawa Y, Jean K, Temime L Aliment Pharmacol Ther. 2022; 56(4):558-569.

PMID: 35758763 PMC: 9543323. DOI: 10.1111/apt.17106.


Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China.

Wang X, Wei L J Clin Transl Hepatol. 2021; 9(3):419-427.

PMID: 34221928 PMC: 8237141. DOI: 10.14218/JCTH.2020.00097.


Risk factors associated with nosocomial infections among end stage renal disease patients undergoing hemodialysis: A systematic review.

Abbasi S, Aftab R, Chua S PLoS One. 2020; 15(6):e0234376.

PMID: 32569265 PMC: 7307739. DOI: 10.1371/journal.pone.0234376.